Insider Trading Activity Seattle Genetics, Inc. (NASDAQ:SGEN) – CMO Sold 10,000 shares of Stock

Insider Trading Activity For Seattle Genetics, Inc. (NASDAQ:SGEN)

Story continues below

Jonathan G. Drachman , CMO of Seattle Genetics, Inc. (NASDAQ:SGEN) reportedly Sold 10,000 shares of the company’s stock at an average price of 54.54 for a total transaction amount of $545,400.00 SEC Form

Insider Trading History For Seattle Genetics, Inc. (NASDAQ:SGEN)

  • On 9/4/2012 Clay B Siegall, CEO, sold 8,250 with an average share price of $26.54 per share and the total transaction amounting to $218,955.00.View SEC Filing
  • On 11/1/2012 Clay B Siegall, CEO, sold 8,250 with an average share price of $25.51 per share and the total transaction amounting to $210,457.50.View SEC Filing
  • On 1/15/2013 Thomas C Reynolds, Insider, sold 125,079 with an average share price of $28.00 per share and the total transaction amounting to $3,502,212.00.View SEC Filing
  • On 2/1/2013 Clay B Siegall, CEO, sold 2,000 with an average share price of $29.61 per share and the total transaction amounting to $59,220.00.View SEC Filing
  • On 2/25/2013 David W Gryska, Director, sold 10,000 with an average share price of $27.17 per share and the total transaction amounting to $271,700.00.View SEC Filing
  • On 3/6/2013 Eric Dobmeier, COO, sold 100,000 with an average share price of $29.68 per share and the total transaction amounting to $2,968,000.00.View SEC Filing
  • On 5/10/2013 Srinivas Akkaraju, Director, sold 17,500 with an average share price of $37.17 per share and the total transaction amounting to $650,475.00.View SEC Filing
  • Analyst Ratings For Seattle Genetics, Inc. (NASDAQ:SGEN)
    These are 3 Sell Ratings, 9 Hold Ratings, 7 Buy Ratings .
    The current consensus rating for Seattle Genetics, Inc. (NASDAQ:SGEN) is Hold (Score: 2.21) with a consensus target price of $61.62 , a potential (22.01% upside)

    Analyst Ratings History For Seattle Genetics, Inc. (NASDAQ:SGEN)

    • On 7/27/2016 SunTrust Banks, Inc. Boost Price Target of rating Neutral with a price target of $34.00 to $38.00
    • On 9/16/2016 Goldman Sachs Group, Inc. (The) Downgraded rating Neutral to Sell
    • On 1/5/2017 Maxim Group Reiterated Rating Reduce
    • On 1/5/2017 Royal Bank Of Canada Set Price Target of rating Buy with a price target of $80.00
    • On 2/13/2017 Credit Suisse Group Boost Price Target of rating Neutral with a price target of $62.00 to $66.00
    • On 2/16/2017 Bank of America Corporation Downgraded rating Neutral to Underperform
    • On 3/16/2017 CIBC Initiated Coverage of rating Market Perform to Market Perform

    Recent Trading Activity for Seattle Genetics, Inc. (NASDAQ:SGEN)
    Shares of Seattle Genetics, Inc. closed the previous trading session at 50.50 down -0.68 -1.33% with 1,237,167 shares trading hands.

    An ad to help with our costs